title: Case study 2: new insights: clinical pearls for using incretin mimetics in type 2 diabetes.
authors.affiliation: The University of Southern California, Clinical Diabetes Programs, Los Angeles, California (Dr Peters)
authors.forename: Anne L
authors.initials: AL
authors.lastname: Peters
authors.affiliation: The USC Westside Center for Diabetes, Beverly Hills, California (Ms Miller)
authors.forename: Donna
authors.initials: D
authors.lastname: Miller
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D000077270:Exenatide; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010455:Peptides / Q000627:therapeutic use*; D014688:Venoms / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D000077270:Exenatide; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms